Evolving Therapeutic Options in Aggressive B-Cell Lymphomas: Expert Guidance for the Community Multidisciplinary Team

This interactive, case-based workshop series will help to effectively personalize the care of patients with aggressive B-cell lymphomas, and provide evidence-based expert perspectives on recent and evolving treatment strategies for the optimal management of patients with these diseases. After the workshop, view the on-demand webcast and download the associated slideset for use in your clinic.

Share

Program Content

Activities

Treatment of Aggressive B Cell Lymphomas
Evolving Therapeutic Options in Aggressive B-Cell Lymphomas: Expert Guidance for the Community Multidisciplinary Team
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 09, 2024

Activities

B Cell Lymphoma Treatment
Evolving Therapeutic Options in Aggressive B-Cell Lymphomas: Expert Guidance for the Community Multidisciplinary Team
Video
Congratulations: You achieved a completion on 04/09/2022

Released: February 28, 2024

Expires: February 27, 2025

Faculty

cover img faculity

Jeremy S. Abramson, MD, MMSc

Director, Center for Lymphoma
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

John N. Allan, MD

Associate Professor of Clinical Medicine
Division of Hematology & Medical Oncology
Weill Cornell Medicine
New York, New York

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca and Incyte Corporation.

AstraZeneca

Incyte Corporation